Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic Acid to Reduce Blood Loss in Acetabular Surgery
NCT02684851Phase 3Completed
- Sponsor
- Wake Forest University Health Sciences
- Start
- Oct 2012
- Primary completion
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in acetabular fracture comparing Placebo with Tranexamic Acid (2 arms). Primary endpoints: Allogenic Blood Transfusion Rates and Units of Packed Red Blood Cells Transfused. Started Oct 2012; status: completed.
02
Drugs
tranexamic acid
03
Conditions
acetabular fracture
Beyond the preview
Go deeper on NCT02684851.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02684851.